Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Signs $29M in New Licensing Deals

NEW YORK, Feb. 24 (GenomeWeb News) - Accelrys yesterday said that in the three months ending Dec. 31, 2005, it entered into "a number of comprehensive, multi-year agreements with some of the world's largest pharmaceutical companies."

The agreements include licenses for Accelrys' computational software and informatics platform totaling $29 million over the term of the agreements, said Accelrys in a statement.

The agreements have durations of two to five years.

No further details were released.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.